BETA BIONICS, INC. (BBNX)

Every figure this model derived for BBNX, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 5,601,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 180,489,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 231,034,000 AssetsCurrent 2026-06-30
current liabilities 26,017,000 LiabilitiesCurrent 2026-06-30
equity 256,366,000 StockholdersEquity 2026-06-30
ocf -55,810,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 119,013,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 21,203,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up BBNX on one particular measure came for.

RatioValue
cash operating margin-50.08
current ratio9.57
current ratio reported8.88
deferred revenue growth64.86
dilution pct537.55
fcf margin-51.6
operating margin-69.75
owner earnings margin-69.42
revenue growth52.54
revenue growth per share-76.07
roic-86.43
rpo growth72.73
rule of 40-17.22
sbc pct revenue17.82

What to be careful about

What this model itself distrusts about BBNX's figures. Written by the derivation as it ran, not added afterwards.